Literature DB >> 27522519

Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain.

Adam R Smith1, Rebecca G Smith1, Daniel Condliffe2, Eilis Hannon1, Leonard Schalkwyk3, Jonathan Mill4, Katie Lunnon5.   

Abstract

Although mutations within the TREM2 gene have been robustly associated with Alzheimer's disease, it is not known whether alterations in the regulation of this gene are also involved in pathogenesis. Here, we present data demonstrating increased DNA methylation in the superior temporal gyrus in Alzheimer's disease brain at a CpG site located 289 bp upstream of the transcription start site of the TREM2 gene in 3 independent study cohorts using 2 different technologies (Illumina Infinium 450K methylation beadchip and pyrosequencing). A meta-analysis across all 3 cohorts reveals consistent AD-associated hypermethylation (p = 3.47E-08). This study highlights that extending genetic studies of TREM2 in AD to investigate epigenetic changes may nominate additional mechanisms by which disruption to this gene increases risk.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AD; Alzheimer's disease; Braak stage; Brain; DNA methylation; Epigenetics; TREM2

Mesh:

Substances:

Year:  2016        PMID: 27522519      PMCID: PMC5747529          DOI: 10.1016/j.neurobiolaging.2016.07.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  29 in total

1.  Variant TREM2 as risk factor for Alzheimer's disease.

Authors:  Harald Neumann; Mark J Daly
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

2.  A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology.

Authors:  Joseph M Replogle; Gail Chan; Charles C White; Towfique Raj; Phoebe A Winn; Denis A Evans; Reisa A Sperling; Lori B Chibnik; Elizabeth M Bradshaw; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Ann Neurol       Date:  2015-03       Impact factor: 10.422

3.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

4.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

5.  Common polygenic variation enhances risk prediction for Alzheimer's disease.

Authors:  Valentina Escott-Price; Rebecca Sims; Christian Bannister; Denise Harold; Maria Vronskaya; Elisa Majounie; Nandini Badarinarayan; Kevin Morgan; Peter Passmore; Clive Holmes; John Powell; Carol Brayne; Michael Gill; Simon Mead; Alison Goate; Carlos Cruchaga; Jean-Charles Lambert; Cornelia van Duijn; Wolfgang Maier; Alfredo Ramirez; Peter Holmans; Lesley Jones; John Hardy; Sudha Seshadri; Gerard D Schellenberg; Philippe Amouyel; Julie Williams
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

6.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

7.  Insights into TREM2 biology by network analysis of human brain gene expression data.

Authors:  Paola Forabosco; Adaikalavan Ramasamy; Daniah Trabzuni; Robert Walker; Colin Smith; Jose Bras; Adam P Levine; John Hardy; Jennifer M Pocock; Rita Guerreiro; Michael E Weale; Mina Ryten
Journal:  Neurobiol Aging       Date:  2013-07-12       Impact factor: 4.673

8.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Missense variant in TREML2 protects against Alzheimer's disease.

Authors:  Bruno A Benitez; Sheng Chih Jin; Rita Guerreiro; Rob Graham; Jenny Lord; Denise Harold; Rebecca Sims; Jean-Charles Lambert; J Raphael Gibbs; Jose Bras; Celeste Sassi; Oscar Harari; Sarah Bertelsen; Michelle K Lupton; John Powell; Celine Bellenguez; Kristelle Brown; Christopher Medway; Patrick C G Haddick; Marcel P van der Brug; Tushar Bhangale; Ward Ortmann; Tim Behrens; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Jonathan L Haines; Jim Turton; Anne Braae; Imelda Barber; Anne M Fagan; David M Holtzman; John C Morris; Julie Williams; John S K Kauwe; Philippe Amouyel; Kevin Morgan; Andy Singleton; John Hardy; Alison M Goate; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2013-12-21       Impact factor: 4.673

View more
  21 in total

Review 1.  Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood.

Authors:  Paula Desplats; Ashley M Gutierrez; Marta C Antonelli; Martin G Frasch
Journal:  Neurosci Biobehav Rev       Date:  2019-11-05       Impact factor: 8.989

2.  Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease.

Authors:  Lixia Qin; Qian Xu; Ziyi Li; Li Chen; Yujing Li; Nannan Yang; Zhenhua Liu; Jifeng Guo; Lu Shen; Emily G Allen; Chao Chen; Chao Ma; Hao Wu; Xiongwei Zhu; Peng Jin; Beisha Tang
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

Review 3.  A putative role for lncRNAs in epigenetic regulation of memory.

Authors:  Ashleigh B Irwin; Rudhab Bahabry; Farah D Lubin
Journal:  Neurochem Int       Date:  2021-09-14       Impact factor: 3.921

Review 4.  Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders.

Authors:  Natalia Salvadores; Mario Sanhueza; Patricio Manque; Felipe A Court
Journal:  Front Neurosci       Date:  2017-09-04       Impact factor: 4.677

5.  Regional differences in mitochondrial DNA methylation in human post-mortem brain tissue.

Authors:  Matthew Devall; Rebecca G Smith; Aaron Jeffries; Eilis Hannon; Matthew N Davies; Leonard Schalkwyk; Jonathan Mill; Michael Weedon; Katie Lunnon
Journal:  Clin Epigenetics       Date:  2017-05-03       Impact factor: 6.551

6.  DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects.

Authors:  Yuta Yoshino; Yuki Ozaki; Kiyohiro Yamazaki; Tomoko Sao; Yoko Mori; Shinichiro Ochi; Jun-Ichi Iga; Shu-Ichi Ueno
Journal:  Front Neurosci       Date:  2017-05-23       Impact factor: 4.677

Review 7.  Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?

Authors:  Gabriela Mazzanti; Silvia Di Giacomo
Journal:  Molecules       Date:  2016-09-17       Impact factor: 4.411

8.  DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.

Authors:  Yvonne Shao; McKenzie Shaw; Kaitlin Todd; Maria Khrestian; Giana D'Aleo; P John Barnard; Jeff Zahratka; Jagan Pillai; Chang-En Yu; C Dirk Keene; James B Leverenz; Lynn M Bekris
Journal:  J Hum Genet       Date:  2018-01-25       Impact factor: 3.172

Review 9.  TREM2 in Neurodegenerative Diseases.

Authors:  Taylor R Jay; Victoria E von Saucken; Gary E Landreth
Journal:  Mol Neurodegener       Date:  2017-08-02       Impact factor: 14.195

10.  Peripheral DNA methylation, cognitive decline and brain aging: pilot findings from the Whitehall II imaging study.

Authors:  Leonidas Chouliaras; Ehsan Pishva; Rita Haapakoski; Eniko Zsoldos; Abda Mahmood; Nicola Filippini; Joe Burrage; Jonathan Mill; Mika Kivimäki; Katie Lunnon; Klaus P Ebmeier
Journal:  Epigenomics       Date:  2018-04-25       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.